home / stock / lnsr / lnsr news


LNSR News and Press, LENSAR Inc.

Stock Information

Company Name: LENSAR Inc.
Stock Symbol: LNSR
Market: NASDAQ
Website: lensar.com

Menu

LNSR LNSR Quote LNSR Short LNSR News LNSR Articles LNSR Message Board
Get LNSR Alerts

News, Short Squeeze, Breakout and More Instantly...

LNSR - 3 Under-$10 Stocks With the Potential to Make You a Millionaire

2024-07-05 10:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Buying low-priced stocks with explosive potential is any investor’s dream — but it’s not easy. Many stocks trade under $10 in the market, yet not all are quality picks. Som...

LNSR - LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript

2024-05-11 15:50:09 ET LENSAR, Inc. (LNSR) Q1 2024 Earnings Conference Call May 09, 2024 08:30 am ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - CEO Thomas Staab - CFO Conference Call Participants Frank Takkinen - Lake Street Cap...

LNSR - LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024

2024-05-09 11:57:59 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips LENSAR (NASDAQ: LNSR ) just reported results for the first quarter of 2024. LENSAR reported earnings per share of -19 cents. This was above the analyst estimate for EPS of...

LNSR - LENSAR GAAP EPS of -$0.19 beats by $0.09, revenue of $10.6M beats by $0.05M

2024-05-09 07:33:47 ET More on LENSAR LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on LENSAR Historical earnings data for LENSAR Financial information for LENSAR Read the full article on Seeking Alpha ...

LNSR - LENSAR Reports First Quarter 2024 Results and Provides Business Update

Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023 Increased ALLY ® Adaptive Cataract Treatment System installed base to 65 systems LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global m...

LNSR - LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s first quarter 2024 financial results will be released ...

LNSR - LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

44 ALLY ® Adaptive Cataract Treatment Systems were placed in 2023, significantly exceeding the target of 30, increasing the ALLY installed base to 54 and a backlog of 9 additional systems as of December 31, 2023 Total revenue increased 18% in the fourth quarter and 19% over full ...

LNSR - Expected US Company Earnings on Monday, March 4th, 2024

Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...

LNSR - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted seven newly-hired non-executive employees stock options to purchase an aggregate of 4,175 shares of the Comp...

LNSR - LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2023 financial results wi...

Next 10